Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Katovich

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Regulatory Peptides|October 13, 2005
Alterations in aortic vascular reactivity to angiotensin 1-7 in 17-beta-estradiol-treated female SD ratsJustin L Grobe, Michael J Katovich
Current Hypertension Reports|January 16, 2002
Genetic targeting of the renin-angiotensin system for long-term control of hypertensionBeverly L Metcalfe, Mohan Raizada, Michael J Katovich
Current Hypertension Reports|September 4, 2008
Angiotensin-(1-7) as an antihypertensive, antifibrotic targetMichael J Katovich, Justin L Grobe, Mohan K Raizada
Current Opinion in Pharmacology|January 11, 2011
ACE2, a promising therapeutic target for pulmonary hypertensionVinayak Shenoy, Yanfei Qi, Michael J Katovich, et al.
Physiology & Behavior|July 15, 2006
Effects of central and peripheral injections of apelin on fluid intake and cardiovascular parameters in ratsAnaya Mitra, Michael J Katovich, Adam Mecca, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2004
Decrease in hypothalamic gamma adducin in rat models of hypertensionHong Yang, Phyllis Y Reaves, Michael J Katovich, et al.
Regulatory Peptides|September 24, 2004
Cloning and characterization of a secreted form of angiotensin-converting enzyme 2Matthew J Huentelman, Jasenka Zubcevic, Michael J Katovich, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 18, 2006
Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertensionJustin L Grobe, Adam P Mecca, Haoyu Mao, et al.
Experimental Physiology|January 11, 2005
Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertensionMichael J Katovich, Justin L Grobe, Matt Huentelman, et al.
Experimental Physiology|May 12, 2009
Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusionAdam P Mecca, Timothy E O'Connor, Michael J Katovich, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Regulatory Peptides|October 13, 2005
Alterations in aortic vascular reactivity to angiotensin 1-7 in 17-beta-estradiol-treated female SD ratsJustin L Grobe, Michael J Katovich
Current Hypertension Reports|January 16, 2002
Genetic targeting of the renin-angiotensin system for long-term control of hypertensionBeverly L Metcalfe, Mohan Raizada, Michael J Katovich
Current Hypertension Reports|September 4, 2008
Angiotensin-(1-7) as an antihypertensive, antifibrotic targetMichael J Katovich, Justin L Grobe, Mohan K Raizada
Current Opinion in Pharmacology|January 11, 2011
ACE2, a promising therapeutic target for pulmonary hypertensionVinayak Shenoy, Yanfei Qi, Michael J Katovich, et al.
Physiology & Behavior|July 15, 2006
Effects of central and peripheral injections of apelin on fluid intake and cardiovascular parameters in ratsAnaya Mitra, Michael J Katovich, Adam Mecca, et al.
Hypertension (Dallas, Tex. : 1979)|January 21, 2004
Decrease in hypothalamic gamma adducin in rat models of hypertensionHong Yang, Phyllis Y Reaves, Michael J Katovich, et al.
Regulatory Peptides|September 24, 2004
Cloning and characterization of a secreted form of angiotensin-converting enzyme 2Matthew J Huentelman, Jasenka Zubcevic, Michael J Katovich, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 18, 2006
Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertensionJustin L Grobe, Adam P Mecca, Haoyu Mao, et al.
Experimental Physiology|January 11, 2005
Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertensionMichael J Katovich, Justin L Grobe, Matt Huentelman, et al.
Experimental Physiology|May 12, 2009
Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusionAdam P Mecca, Timothy E O'Connor, Michael J Katovich, et al.
Pageof 6